Skip to main content
Equibles
MCK logo

MCK · Mckesson Corp

Track MCK — free

Use MCK with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about MCK

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$893.39 +2.88 (+0.32%) At close · Aug 28
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$103.82B
Shares
116.59M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$893.39 Open$895.04 Day$890.80–900.22 52W close$681.02–995.69 Avg vol 30d970K Short int2.4M · 2.1% float · 2.2d Short vol68% Last earningsAug 5, 2026 DataJan 2020–Aug 2026 Filing10-Q · Aug 5

Up next

Next earnings call
Nov 5, 2026 Est · unconfirmed · in 10 wks
FQ2-27 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 5, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Buy
      SellHoldBuy
      Technical Buy Momentum Neutral Sentiment Neutral Fundamentals Excellent Quant / Vol Moderate
      Market backdrop VIX 14.4 · calm Equity put/call 0.62
      Technical
      price trend
      Buy
      50 / 200-day cross No cross
      Price vs 200-day avg +6%
      above
      Price vs 50-day avg +7%
      above
      RSI (14) 58
      neutral
      MACD trend Positive
      52-week position 67%
      mid-range
      Volume (OBV) Bearish div.
      distributing
      Momentum
      relative strength
      Neutral
      1-month return +4%
      trailing
      6-month return −5%
      trailing
      YTD return +9%
      this year
      Relative strength −19%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $832 › 200d $842 — 200d above 50d
      Institutional flow Distributing
      -2% holders QoQ · +170 funds added
      Insider flow Distributing
      Net -$268.6K over 90 days · 100% sells
      Short interest Falling
      2.08% of float · ▼ -33.0% MoM · 2.2 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      2,010 holders — near 3-yr high, broad support
      Squeeze score 49
      elevated · 0–100
      Fundamentals
      Excellent
      Revenue growth +3%
      Y/Y
      Gross margin 13%
      expanding
      EPS growth +49%
      Y/Y
      Free cash flow $5.7B
      Balance sheet $2.5B
      net debt
      Quant / Vol
      risk profile
      Moderate
      Volatility 31%
      annualized · 1-yr
      Max drawdown −27%
      past year
      ATR 2.7%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Beat or met 1 of last 2
      Latest guidance · from the 8-K filed Aug 5, 2026
      Adjusted Earnings per Diluted Share · Fiscal 2027 Full Year Non-GAAP Raised $44.20 – $45.00
      May 7, 2026 $43.80 – $44.60 changed to Aug 5, 2026 $44.20 – $45.00
      Prior guidance period ended · from the 8-K filed Feb 5, 2025
      Adjusted Earnings per Diluted Share · fiscal 2025 $32.55 – $32.95
      Guided vs delivered · last 2 settled
      Earnings per diluted share fiscal 2025
      guided $31.25 – $32.05
      $25.72 Miss −18.7%
      European operations operating profit contribution per diluted sh fiscal 2023
      guided $0.85 – $1.00
      $25.03 Beat +2605.9%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Buy
      1 · 3 · 3
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +6% Bullish
      Price vs 50-day avg
      +7% Bullish
      RSI (14)
      58 Neutral
      MACD trend
      Positive Bullish
      52-week position
      67% Neutral
      Volume (OBV)
      Bearish div. Bearish
      Market signals — smart money & positioning
      Mixed
      Trend (MA cross) No cross
      50d $832 › 200d $842 — 200d above 50d
      Institutional flow Distributing
      -2% holders QoQ · +170 funds added
      Insider flow Distributing
      Net -$268.6K over 90 days · 100% sells
      Short interest Falling
      2.08% of float · ▼ -33.0% MoM · 2.2 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      2,010 holders — near 3-yr high, broad support
      Price context
      position in its 52-week range
      Range low $681 Now $893 · 67% Range high $996
      vs 200-day avg +6% vs 50-day avg +7%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      GAAP → non-GAAP reconciliation
      GAAP Net income attributable to McKesson Corporation 614M
      +74M Amortization of acquisition-related intangibles
      +108M Transaction-related expenses and adjustments
      -2M LIFO inventory-related adjustments
      -6M Gains from antitrust legal settlements
      +136M Restructuring, impairment, and related charges, net
      -34M Claims and litigation charges, net
      -6M Other adjustments, net
      -64M Income tax effect on pre-tax adjustments
      +363M Net income attributable to noncontrolling interests effect on pre-tax adjustments and redeemable noncontrolling interests adjust
      = Adjusted Earnings 1.18B
      GAAP → non-GAAP reconciliation
      GAAP Earnings per diluted common share attributable to McKesson Corporation $5.15
      +$0.41 Amortization of acquisition-related intangibles
      +$3.85 Transaction-related expenses and adjustments
      -$0.02 LIFO inventory-related adjustments
      -$0.03 Gains from antitrust legal settlements
      +$0.82 Restructuring, impairment, and related charges, net
      -$0.21 Claims and litigation charges, net
      -$0.04 Other adjustments, net
      = Adjusted Earnings per Diluted Share $9.93
      Adjusted Corporate Expenses (Non-GAAP) non-GAAP -$654M Year Ended March 31, 2026 —
      Adjusted Income Tax Expense (Non-GAAP) non-GAAP -$1.14B Year Ended March 31, 2026 —
      Adjusted Operating Profit (Non-GAAP) non-GAAP $6.47B Year Ended March 31, 2026 —
      Adjusted Segment Operating Profit non-GAAP $322M FY26 Q4 —
      Adjusted Segment Operating Profit (Non-GAAP) - Medical-Surgical Solutions non-GAAP $1.03B Year Ended March 31, 2026 —
      Adjusted Segment Operating Profit (Non-GAAP) - North American Pharmaceutical non-GAAP $3.45B Year Ended March 31, 2026 —
      Adjusted Segment Operating Profit (Non-GAAP) - Oncology & Multispecialty non-GAAP $1.44B Year Ended March 31, 2026 —
      Adjusted Segment Operating Profit (Non-GAAP) - Prescription Technology Solutions non-GAAP $1.13B Year Ended March 31, 2026 —
      Adjusted Segment Operating Profit Margin (Non-GAAP) - Medical-Surgical Solutions non-GAAP 8.94% Year Ended March 31, 2026 —
      Adjusted Segment Operating Profit Margin (Non-GAAP) - North American Pharmaceutical non-GAAP 1.24% Three Months Ended March 31, 2026 —
      Adjusted Segment Operating Profit Margin (Non-GAAP) - Oncology & Multispecialty non-GAAP 2.96% Year Ended March 31, 2026 —
      Adjusted Segment Operating Profit Margin (Non-GAAP) - Prescription Technology Solutions non-GAAP 19.45% Year Ended March 31, 2026 —

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Medical Distribution — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      MCK
      Mckesson Corp
      this stock
      		$103.82B +8.9% +3.1% 23.9 2.1%
      COR
      Cencora, Inc.
      		 $61.58B -4.7% +9.3% 24.0 2.4%
      CAH
      Cardinal Health Inc
      		 $54.69B +14.1% +14.2% — 2.7%
      HSIC
      Henry Schein Inc
      		 $10.06B +18.4% +5.9% 26.3 6.2%
      EBOSY
      EBOS Group Limited/ADR
      		 $2.69B — — — 0.0%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Reducing
      Holders
      2,010
      % held
      91.3%
      Net QoQ
      -1.6M sh
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      1,128
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      2.4M
      Days to cover
      2.2d
      Change
      -1.2M sh
      View
      Short Volume
      Short vol %
      68%
      As of
      Aug 28, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      6.0K
      Value
      $5.0M
      As of
      Jul 24, 2026
      View
      Off-Exchange
      Off-exchange %
      44.6%
      Week of
      Jul 20, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net selling
      Net (90d)
      -$268.6K
      Buyers / Sellers
      0 / 1
      Buyers Sellers
      View
      Congressional Trades Buy
      Member
      Rick Larsen
      Amount
      $1.0K–$15.0K
      Traded
      Jul 8, 2026
      View
      Financials
      Financials
      Revenue (FY)
      $403.4B
      Net income (FY)
      $4.8B
      EPS diluted
      $38.38
      View
      Buybacks
      Authorized
      shares 2.3B
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Aug 28, 2026
      This year
      16
      View
      Proposed Sales
      Value
      $268.6K
      Shares
      301
      Filed
      Aug 10, 2026
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 5, 2026
      View
      Investor Relations
      Latest news
      McKesson Corporation Raises Quart…
      Published
      Jul 22, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      MCK +4.0% +4.3% -5.2% +4.3% +8.9%
      SPY +0.5% +3.0% +13.4% +3.0% +12.8%
      vs SPY +3.6% +1.4% -18.6% +1.4% -3.9%

      Capital returns

      Latest dividend
      $0.82 / share · ex Jun 1, 2026
      Declared · upcoming
      $0.94 / share · ex Sep 1, 2026
      Raised 15.5%
      Paid (TTM)
      $3.28 / share · 4 payouts
      Dividend yield (TTM, derived)
      0.37%
      Buyback program · as of May 31, 2026
      Authorized
      shares 2.30B
      Spent (derived)
      —
      Remaining
      —

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 927653 CUSIP 58155Q103 13F (30d) 1318 filings 1262 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)